Oncternal Therapeutics (ONCT) said late Thursday it entered into a collaboration with AbbVie's (ABBV) Pharmacyclics unit that includes supply of ibrutinib...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
Oncternal Therapeutics (ONCT) said Wednesday that it has deprioritized the development of ONCT-216 to reallocate resources to zilovertamab, which is...
...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
Here's how the stocks on Tuesday's After Hours Watch List performed during today's regular session: AFTER HOURS REGULAR SESSION WEJO +27.8% ...
Here are some of the stocks moving in after-hours trading worth watching in Wednesday's regular session: WEJO:+27.8%; Says developing vehicle data...
Oncternal Therapeutics (ONCT) said late Tuesday it has agreed with the US Food and Drug Administration a study design and "major details" of a phase 3...
Oncternal Therapeutics (ONCT) said Tuesday its drug candidate ONCT-534 has shown anti-tumor activity in a series of pre-clinical studies and may become a...
Oncternal Therapeutics (ONCT) and Celularity (CELU) said Monday they entered a research partnership to evaluate placental derived-cellular therapies...